Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 Diabetics [Phase 1]
Phase 1 study to evaluate the pharmacodynamic effects of single-dose co-administration of LX4211 (sotagliflozin) with Januvia (sitagliptin) …
-
FDA approval · 2012-01-30FDA Approved: JENTADUETO — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved JENTADUETO (linagliptin and metformin hydrochloride) under an Original Application by Boehringer Ingelheim Pharmaceuticals, Inc…
-
FDA label_change · 2012-01-30FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2012-01-30Clinical Trial Update: A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081) [Phase 1]
Phase 1 study in adolescents evaluated the pharmacokinetics, safety and tolerability of sitagliptin for type 2 diabetes. Results were posted…
-
CLINICAL_TRIALS trial_result · 2012-01-27Clinical Trial Update: Study of INT-747 in Patients With Diabetes and Presumed NAFLD [Phase 2]
Phase 2 clinical trial update for obeticholic acid (INT-747) in patients with type 2 diabetes mellitus and presumed non-alcoholic fatty live…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-01-27Clinical Trial Update: Diabetes in Europe - Prevention Using Lifestyle, Physical Activity and Nutritional Intervention in Catalonia [NA]
This clinical trial update describes a European study in Catalonia evaluating lifestyle, physical activity, and nutritional interventions to…
-
FDA approval · 2012-01-26FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for METFORMIN HYDROCHLORIDE by Granules Pharmaceuticals Inc., granting regulatory acceptance for thi…
-
CLINICAL_TRIALS other · 2012-01-24Clinical Trial Update: Balance System Study in Type 2 Diabetic Patients [Phase 1]
A Phase 1 clinical trial update of the Balance System in adults with type 2 diabetes mellitus and obesity; the study sponsored by Beta-Stim …
-
CLINICAL_TRIALS trial_result · 2012-01-23Clinical Trial Update: A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199)
A completed clinical trial evaluating current medical practice and outcomes in the treatment of Type 2 Diabetes Mellitus in an office settin…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263) [Phase 4]
Phase 4 clinical trial assessing sitagliptin treatment in patients with type 2 diabetes during Ramadan completed with results posted in 2012…
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis [Phase 4]
Phase 4 clinical trial update assessing whether adalimumab affects cardiovascular and metabolic risk in patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients [Phase 1]
Phase 1 study evaluating the relative bioavailability of several AZD1656 tablet formulations in patients with Type 2 Diabetes Mellitus has b…
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: WelChol® With Metformin in Treating Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating WelChol (cholestyramine) in combination with metformin for Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: WelChol® and Insulin in Treating Patients With Type 2 Diabetes [Phase 3]
Phase 3 clinical trial evaluating WelChol (colesevelam) with insulin in type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating WelChol (colesevelam) in combination with a sulfonylurea in patients with Type 2 diabetes mellitus has completed.
-
FDA approval · 2012-01-18FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' metformin hydrochloride product under an Original Application (ANDA201991), providing a generic option…
-
CLINICAL_TRIALS trial_result · 2012-01-16Clinical Trial Update: Comparison of Efficacy of Vitamin D and Vitamin D-calcium Fortified Yogurt Drink in Diabetic Patients [Phase 2]
Phase 2 trial comparing Vitamin D alone versus a Vitamin D-calcium fortified yogurt drink in adults with Type 2 diabetes; results have been …
-
CLINICAL_TRIALS trial_result · 2012-01-16Clinical Trial Update: Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial evaluating the metabolic and haemodynamic effects of metformin and glimepiride in patients with type 2 diabetes melli…
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients [Phase 3]
A Phase 3 trial evaluating a fixed-dose rosiglitazone/glimepiride combination for Type 2 diabetes in Chinese patients was terminated; result…
-
CLINICAL_TRIALS trial_result · 2012-01-11Clinical Trial Update: A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients [Phase 1]
This Phase 1 trial reports the safety and tolerability results for a single oral dose of AZD6370 (P-Glucose) in adults with Type 2 diabetes …
-
CLINICAL_TRIALS research · 2012-01-11Clinical Trial Update: Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects [Phase 4]
A Phase 4 clinical trial comparing insulin glargine as a first-line therapy to metformin in type 2 diabetes has completed, with the registry…
-
CLINICAL_TRIALS trial_result · 2012-01-09Clinical Trial Update: The Effect of a Nutritional Supplement in Individuals With Type 2 Diabetes Mellitus: a Pilot Study [Phase 1]
Phase 1 pilot study evaluating the effects of a nutritional supplement in adults with type 2 diabetes and insulin resistance; study status i…
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination [Phase 4]
Phase 4 clinical trial evaluating predictive parameters for the efficacy of the sitagliptin and metformin combination in diabetes.
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Exercise Intensity, Glycemic Control and Abdominal Fat in People With Type 2 Diabetes: A Pilot Study [NA]
A completed pilot clinical trial examined whether exercise intensity affects glycemic control and abdominal fat in people with Type 2 Diabet…
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes [Phase 4]
Phase 4 study evaluating saxagliptin added to metformin versus uptitration of metformin in adults with Type 2 diabetes, focusing on efficacy…